Wyeth “Unfairly” Delaying Materna Patent Award With Appeal, Innovator Says
This article was originally published in The Tan Sheet
Executive Summary
Wyeth appealed a $58 mil. patent infringement award for an old prenatal vitamin line to the Supreme Court on Feb. 10, the company said
You may also be interested in...
Wyeth Materna Case Closes As Firm Runs Out Of Options
The U.S. Supreme Court will not hear Wyeth's appeal of a $58.3 mil. judgment for patent fraud and unjust enrichment, ending an 11-year court battle in the Materna prenatal vitamin line case
Wyeth Materna Case Closes As Firm Runs Out Of Options
The U.S. Supreme Court will not hear Wyeth's appeal of a $58.3 mil. judgment for patent fraud and unjust enrichment, ending an 11-year court battle in the Materna prenatal vitamin line case
Wyeth Materna Case Closes As Firm Runs Out Of Options
The U.S. Supreme Court will not hear Wyeth's appeal of a $58.3 mil. judgment for patent fraud and unjust enrichment, ending an 11-year court battle in the Materna prenatal vitamin line case